Hard to think Dunn would of resigned on the assumed basis that Trof is about to be declined for approval unless he’s the most ethical man known to mankind who doesn’t want to work for the FDA based on their decision.
Also hard to believe that the decision to approve or decline has been left to the 11th hour - I believe the decision has been made and they are just waiting to announce it.
No advisory committee meeting is a good sign in my opinion as there doesn’t seem a need to have a panel to discuss the drug - in my mind that tells me it’s either a clear cut approval or rejection.
if it’s rejected the rett community will be ropeable
Interesting Bell Potter thoughts..., page-4
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.14 |
Change
-0.130(0.85%) |
Mkt cap ! $1.935B | |||
| Open | High | Low | Value | Volume |
| $15.38 | $15.47 | $14.93 | $7.335M | 485.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7079 | $15.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.17 | 3189 | 3 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |